Procalcitonin levels and some hemostasis indicators as prognostic markers

Abstract

Diabetes mellitus is recognized as one of the main comorbid pathologies that contribute to the severe course and unfavorable prognosis in patients with acute respiratory viral disease COVID-19. It is suggested that this development is associated with an imbalance between the coagulation system and fibrinolysis, which increases the likelihood of thromboembolism in these patients. This leads to further careful study of some indicators of hemostasis.